EUVIMEDEUVIMED entdecken
Crossref

The Effect of Magnesium Sulfate (MgSO4) Treatment for Fetal Neuroprotection on Maternal Inflammation and Immune Response

Harun Kızılay, Cengizhan Ceylan, Şeyma Tetik Rama, Dilara Ertuğrul, Yasin Altekin, Gokcen Orgul

Genel Tıp Dergisi · 29.07.2026 · 36 (2026) · 1-5

DOI: 10.54005/geneltip.1810170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genel Tıp Dergisi, online erschienen am 29.07.2026. Verfasst von Harun Kızılay und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Gefördert von: None.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The aim of this study is to retrospectively evaluate the effects of antenatal MgSO4 administration on maternal inflammatory response indicators NLR, SII, and SIRI.Materials and Methods: Between January 2021 and December 2023, 35 pregnant women who were followed up in the perinatology department of a medical faculty hospital, who were administered MgSO4 for fetal neuroprotection at ≤ 32 weeks, and whose data were obtained from the electronic record system were retrospectively examined. Baseline and post-MgSO4 leukocyte, neutrophil, lymphocyte, monocyte, and platelet values were recorded at 12 hours. NLR, SII, and SIRI calculations were performed using standard formulas. Continuous data were compared using the t-test for dependent groups, and categorical data were analyzed using the chi-square test; p < 0.05 was considered statistically significant.

Results

The mean gestational age was 29.8 ± 2.2 weeks, and the mean birth weight was 1363 ± 413 g. A significant increase in leukocyte and neutrophil counts was observed after MgSO4 administration (p < 0.05), while no significant changes were detected in lymphocyte, monocyte, and platelet counts (p > 0.05). NLR and SIRI increased significantly (p < 0.05), while the increase in SII was not significant (p > 0.05).

Conclusion

MgSO4 administration has a variable effect on maternal inflammatory response parameters; NLR and SIRI increase, while no significant change is observed in SII. These findings should be confirmed in prospective, randomized studies with larger sample sizes.

Förderung

  • None

Zitieren

APA

Kızılay, H., Ceylan, C., Rama, Ş. T., Ertuğrul, D., Altekin, Y., & Orgul, G. (2026). The Effect of Magnesium Sulfate (MgSO4) Treatment for Fetal Neuroprotection on Maternal Inflammation and Immune Response. Genel Tıp Dergisi, 36(2026), 1-5. https://doi.org/10.54005/geneltip.1810170

Vancouver

Kızılay H, Ceylan C, Rama ŞT, Ertuğrul D, Altekin Y, Orgul G. The Effect of Magnesium Sulfate (MgSO4) Treatment for Fetal Neuroprotection on Maternal Inflammation and Immune Response. Genel Tıp Dergisi. 2026;36(2026):1-5. doi:10.54005/geneltip.1810170

BibTeX
@article{Kzlay2026,
  author = {Kızılay, Harun and Ceylan, Cengizhan and Rama, Şeyma Tetik and Ertuğrul, Dilara and Altekin, Yasin and Orgul, Gokcen},
  title = {The Effect of Magnesium Sulfate (MgSO4) Treatment for Fetal Neuroprotection on Maternal Inflammation and Immune Response},
  journal = {Genel Tıp Dergisi},
  year = {2026},
  volume = {36},
  number = {2026},
  pages = {1--5},
  doi = {10.54005/geneltip.1810170}
}
Kostenlos starten →